Safety and efficacy of extended treatment with tezacaftor/ivacaftor

Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Safety and efficacy of extended treatment with tezacaftor/ivacaftor

Resource Type

CF Research News

Authors

Patrick A Flume, R Scott Harris, Hildegarde Paz-Diaz, Neil Ahluwalia, Mark Higgins, Daniel Campbell, Indrias Berhane, Judy L Shih, Gregory Sawicki

References

J Cyst Fibros. 2022 Dec 27;S1569-1993(22)01426-6. doi: 10.1016/j.jcf.2022.12.006

Document

CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Pulmonology [3]

Keywords

F508del [4]

Ivacaftor [5]

Phase 3 [6]

Tezacaftor [7]

Date

Tuesday, December 27, 2022

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]

Source URL:https://www.ecfs.eu/resource-article/cf-research-news/safety-and-efficacy-extended-treatment-tezacaftorivacaftor

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-22-00239R1_FINAL_Flume_010523.pdf [2] https://pubmed.ncbi.nlm.nih.gov/36581484/ [3] https://www.ecfs.eu/research-article-themes/pulmonology [4] https://www.ecfs.eu/research-article-keywords/f508del [5] https://www.ecfs.eu/research-article-keywords/ivacaftor [6] https://www.ecfs.eu/research-article-keywords/phase-3 [7] https://www.ecfs.eu/research-article-keywords/tezacaftor [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines